Table 1 Characteristics of patients with active and inactive inflammatory bowel disease (IBD) and of controls.

N

10

5

6

5

2

id numbers

c¹1, c2, c3, c4, c5, c6, c12, c14, c16, c17

p10, p23, p26, p27, p32

p7, p8, p13, p19, p22, p25

p11, p15, p18, p20, p31

p29, p30

M/F

6/4

2/13

5/1

1/4

2/0

mean age

27 (21–33)

40 (37–54)

42 (34–71)

48 (34–65)

48

localization of disease, (present when active, previous when inactive)

None

Proctosigmoid colon (p10, p23, p26), pancolitis (p32), rectum (p27)

rectum (p8), proctosigmoid colon (p7, p19, p22),

pancolitis (p13, p25)

descending colon (p15, p18, p20),

proctosigmoid colon (p14, p31)

colon with skip lesions (p29),

proctosigmoid colon (p30)

Medication

None

5-ASA (p10, p23, p26),

azathioprine (p27),

none (p32)

5-ASA (all),

Azathioprine (p13, p19),

prednisolone (p13)

None (p15, p18, p31),

5-ASA (p20),

prednisolone (p11)

5-ASA (p29), none

(p30)